TMEM63C inhibitors encompass a variety of compounds that interact with calcium and sodium ion channels, as well as calmodulin, to potentially exert their effects. As a transmembrane protein, TMEM63C's activity is hypothesized to be sensitive to the electrochemical gradient across the plasma membrane, which is influenced by the concentration of specific ions. Compounds that alter this gradient, such as calcium channel blockers, can therefore indirectly inhibit TMEM63C. These inhibitors work by reducing the influx of calcium ions, which can affect the membrane potential and ion balances critical for the function of ion-sensitive proteins like TMEM63C. The modification of these gradients could lead to a decreased activity of TMEM63C, as its functionality may be closely tied to the proper regulation of ion flow across the membrane.
Additionally, certain inhibitors target other mechanisms that could indirectly modulate the activity of TMEM63C. For example, blocking receptor-mediated calcium entry could change the cellular calcium environment, which might be crucial for maintaining TMEM63C activity. Calmodulin antagonists also play a role by disrupting calcium signaling pathways. These compounds achieve their inhibitory effect by potentially modifying the interactions and signaling events that TMEM63C is involved in, altering the balance of ions that TMEM63C may regulate or be regulated by.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Calcium channel blocker that by inhibiting calcium influx can alter membrane potential and thus can indirectly inhibit TMEM63C, which may be sensitive to changes in ionic balances across the membrane. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
A calcium channel blocker that reduces calcium ion concentration, potentially affecting TMEM63C activity by modifying the transmembrane electrochemical gradient. | ||||||
Gadolinium(III) chloride | 10138-52-0 | sc-224004 sc-224004A | 5 g 25 g | $150.00 $350.00 | 4 | |
Blocks stretch-activated ion channels; may decrease TMEM63C activity by interfering with ion movement that TMEM63C may regulate. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $184.00 $245.00 | 13 | |
Non-selective blocker of several cation channels; could impair TMEM63C's functionality by altering ion homeostasis it may control. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $290.00 | 7 | |
Sodium channel inhibitor that may indirectly inhibit TMEM63C by affecting sodium ion balance and membrane potential. | ||||||
Bepridil | 64706-54-3 | sc-507400 | 100 mg | $1620.00 | ||
Inhibits voltage-gated calcium channels, potentially impacting TMEM63C activity by altering the transmembrane potential and ion fluxes. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
L-type calcium channel blocker that might indirectly inhibit TMEM63C by influencing calcium-dependent processes it may be involved in. | ||||||
Flunarizine | 52468-60-7 | sc-337841 | 5 g | $560.00 | ||
Calcium channel blocker that might indirectly inhibit TMEM63C by altering transmembrane calcium flux which TMEM63C may regulate. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $101.00 $155.00 $389.00 $643.00 | 2 | |
A blocker of receptor-mediated calcium entry channels that may indirectly inhibit TMEM63C by changing the cellular calcium environment and affecting the ion channels TMEM63C may interact with. | ||||||